Committee on the Safety of Medicines

Committee on the Safety of Medicines (1988) Benzodiazepines, dependence and withdrawal symptoms , Current Problems, no. 21 (January). 

The advisory role of the CHMP in the EU is similar to the advisory role of the Committee on the Safety of Medicines in the UK. 

Medicines Control Agency, the Committee on the Safety of Medicines and the Medicines Commission, based on the product s possible use, any side effects and risk of its misuse. POMs and certain pharmacy sales medicines must not be promoted to the general public, but can be marketed to the medical profession. The Association of the British Pharmaceutical Industry (ABPI) Code of Practice regulates promotional activities (Association of the British Pharmaceutical Industry, 2001). 

On the advice of the Committee on the Safety of Medicines (now the Commission on Human Medicines), benzodiazepines are indicated for the short-term relief of anxiety that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness. 

What is the Committee on the Safety of Medicines (now Commission on Human Medicines) recommendation for the use of benzodiazepines ... 

Committee on the Safety of Medicines/Medicines Control Agency. Relative safety of oral non-aspirin NSAIDs, Current Problems (1994) 20,9-11. 

Committee on the Safety of Medicines (UK). Message from Professor A Breckenridge (Chairman of CSM) and Fact Sheet for Health Care Professionals, 29th February 2000. 

GSM. 2003. Possible interaction between warfarin and cranberry juice. Committee on the Safety of Medicines. Curr. Prob. Pharmaccfvigilance 29 8. 

---